Emerging Trends in Molecular Imaging


Meeting
Date: 2023-04-19 to 2023-04-20

On behalf of our MMMI Italian Node and the Scientific and Local Organizing Committees, we are pleased to announce the first Workshop on “Emerging Trends in Molecular Imaging” (flyer below) co-organized with the Italian Discussion Group on Magnetic Resonance (GIDRM).

The workshop intends to provide the attendants with the state-of-the-art and future perspectives of emerging technologies/methodologies in the field of molecular imaging. The scientific program will be organized in six sessions covering the following topics: Nuclear Imaging, Optical Imaging/PDT, MRI with paramagnetic agents, CEST-MRI, Hyperpolarized MRI, Prepolarized MRI at earth field.

The following invited experts in the field will give a talk at the workshop:

  • •Prof. Michal Neeman (Weizmann Institute, Israel)
  • •Prof. Calogero D’Alessandria (TUM, Germany)
  • •Prof. Laura Mezzanotte (Erasmus MC, The Netherlands)
  • •Prof. Francois Lux (University Lyon 1, France)
  • •Prof. Andrè Martins (University Hospital Tübingen, Germany)
  • •Prof. Christoffer Laustsen (University Hospital of Aarhus, Denmark)
  • •Prof. Philippe Massot (CNRS, France)
  • •Prof. Elodie Parzy (University Bordeaux, France)
  • In addition, Oral and Poster scientific contribution will be selected from the submitted abstract.

    When

    From April 19th (welcome 2.30 pm) to 20th 2023 (farewell 1 pm)

    Where

    Department of Molecular Biotechnology and Health Sciences/Molecular Biotechnology Center “Guido Tarone” of the University of Torino, Via Nizza 52, Torino (Italy)

    Dates:

    Deadline abstract submission: March 6th, 2023, 23:59 (CET)

    Notification abstract evaluation: March 13th, 2023

    Deadline registration: March 31st, 2023

    More information available

    http://www.gidrm.org/wp/event/imaging2023



    We use cookies to manage and improve the services of the Euro-BioImaging Web Portal. To find out more, read our Privacy policy.
    Please note: For best experience we do not recommend using Internet Explorer.

    80